Venus Medtech (Hangzhou) Inc.
HKEX:2500.HK
3.7 (HKD) • At close August 29, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | 2019 Q2 | 2018 Q4 | 2018 Q2 | 2017 Q4 | 2017 Q2 | 2016 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 240.113 | 230.72 | 235.763 | 255.61 | 196.496 | 104.983 | 207.931 | 207.931 | 138.024 | 138.024 | 116.636 | 116.636 | 58.318 | 57.674 | 28.837 | 9.082 | 4.541 |
| Cost of Revenue
| 54.127 | 48.96 | 47.807 | 54.361 | 46.673 | 22.895 | 45.759 | 45.759 | 24.384 | 24.384 | 19.304 | 19.304 | 9.652 | 8.184 | 4.092 | 1.539 | 0.769 |
| Gross Profit
| 185.986 | 181.76 | 187.956 | 201.249 | 149.823 | 82.088 | 162.172 | 162.172 | 113.64 | 113.64 | 97.333 | 97.333 | 48.666 | 49.49 | 24.745 | 7.544 | 3.772 |
| Gross Profit Ratio
| 0.775 | 0.788 | 0.797 | 0.787 | 0.762 | 0.782 | 0.78 | 0.78 | 0.823 | 0.823 | 0.834 | 0.834 | 0.834 | 0.858 | 0.858 | 0.831 | 0.831 |
| Reseach & Development Expenses
| 160.351 | 180.834 | 230.2 | 294.715 | 307.135 | 110.158 | 129.168 | 129.168 | 83.626 | 83.626 | 100.266 | 100.266 | 50.133 | 52.387 | 26.194 | 58.68 | 29.34 |
| General & Administrative Expenses
| 69.451 | 76.575 | 75.893 | 77.893 | 121.633 | 27.373 | 64.293 | 64.293 | 52.032 | 52.032 | 98.804 | 98.804 | 49.402 | 16.322 | 8.161 | 5.618 | 2.809 |
| Selling & Marketing Expenses
| 114.077 | 130.989 | 142.566 | 157.911 | 137.025 | 61.679 | 108.034 | 108.034 | 67.286 | 67.286 | 62.284 | 62.284 | 31.142 | 33.433 | 16.716 | 17.961 | 8.981 |
| SG&A
| 184.255 | 206.837 | 209.43 | 244.833 | 255.076 | 90.843 | 172.326 | 172.326 | 119.318 | 119.318 | 161.088 | 161.088 | 80.544 | 49.754 | 24.877 | 23.579 | 11.79 |
| Other Expenses
| -17.934 | 0 | 0 | 0 | 0 | 0 | -3.344 | -3.344 | -14.875 | -14.875 | -4.595 | -4.595 | -2.297 | 94.592 | 47.296 | 2.226 | 1.113 |
| Operating Expenses
| 326.672 | 387.671 | 555.883 | 540.403 | 1,068.186 | 196.091 | 298.151 | 298.151 | 188.069 | 188.069 | 256.759 | 256.759 | 128.379 | 196.733 | 98.367 | 84.485 | 42.242 |
| Operating Income
| -140.686 | -205.911 | -249.464 | -338.299 | -434.36 | -118.913 | -310.764 | -310.764 | -118.623 | -118.623 | -184.114 | -186.244 | -93.122 | -148.15 | -74.075 | -77.261 | -38.631 |
| Operating Income Ratio
| -0.586 | -0.892 | -1.058 | -1.323 | -2.211 | -1.133 | -1.495 | -1.495 | -0.859 | -0.859 | -1.579 | -1.597 | -1.597 | -2.569 | -2.569 | -8.507 | -8.507 |
| Total Other Income Expenses Net
| -386.446 | -7.67 | -115.537 | -32.04 | -475.578 | -4.29 | -52.799 | -52.799 | -3.618 | -3.618 | 4.584 | -15.77 | -2.264 | -1.661 | -0.83 | -1.463 | -0.732 |
| Income Before Tax
| -527.132 | -213.581 | -365.001 | -370.339 | -909.938 | -123.203 | -188.778 | -188.778 | -92.922 | -92.922 | -190.772 | -190.772 | -95.386 | -149.81 | -74.905 | -78.724 | -39.362 |
| Income Before Tax Ratio
| -2.195 | -0.926 | -1.548 | -1.449 | -4.631 | -1.174 | -0.908 | -0.908 | -0.673 | -0.673 | -1.636 | -1.636 | -1.636 | -2.598 | -2.598 | -8.668 | -8.668 |
| Income Tax Expense
| -28.096 | 4.756 | 2.16 | 4.124 | 27.564 | 3.369 | -3.081 | -3.081 | -1.488 | -1.488 | -0.389 | -0.389 | -0.195 | 0.449 | 0.225 | 0.25 | 0.125 |
| Net Income
| -507.82 | -206.487 | -353.566 | -350.188 | -857.766 | -99.967 | -185.697 | -185.697 | -91.434 | -91.434 | -190.383 | -190.383 | -95.191 | -150.259 | -75.13 | -78.974 | -39.487 |
| Net Income Ratio
| -2.115 | -0.895 | -1.5 | -1.37 | -4.365 | -0.952 | -0.893 | -0.893 | -0.662 | -0.662 | -1.632 | -1.632 | -1.632 | -2.605 | -2.605 | -8.696 | -8.696 |
| EPS
| -1.29 | -0.48 | -0.8 | -0.8 | -1.96 | -0.23 | -0.42 | -0.42 | -0.22 | -0.22 | -0.6 | -0.62 | -0.31 | -0.38 | -0.19 | -0.2 | -0.1 |
| EPS Diluted
| -1.29 | -0.48 | -0.8 | -0.8 | -1.96 | -0.23 | -0.42 | -0.42 | -0.22 | -0.22 | -0.6 | -0.62 | -0.31 | -0.38 | -0.19 | -0.2 | -0.1 |
| EBITDA
| -450.207 | -162.75 | -208.73 | -295.297 | -399.068 | -96.063 | -162.015 | -162.015 | -76.416 | -76.416 | -176.123 | -167.5 | -85.895 | -143.128 | -71.564 | -74.105 | -37.052 |
| EBITDA Ratio
| -1.875 | -0.705 | -0.885 | -1.155 | -2.031 | -0.915 | -0.779 | -0.779 | -0.554 | -0.554 | -1.51 | -1.436 | -1.473 | -2.482 | -2.482 | -8.159 | -8.159 |